CA Stock MarketDetailed Quotes

HLS Therapeutics Inc (HLS)

Watchlist
  • 4.590
  • -0.060-1.29%
15min DelayMarket Closed Apr 24 16:00 ET
143.55MMarket Cap-5.39P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

HLS Therapeutics Inc (HLS) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
114.04%17.13M
103.03%6.51M
64.96%2.48M
82.77%4.6M
355.40%3.54M
-49.31%8M
-14.17%3.21M
-72.03%1.5M
-5.58%2.52M
-80.65%778K
Net income from continuing operations
36.76%-12.43M
55.84%-1.34M
19.12%-3.92M
51.76%-2.74M
27.35%-4.44M
28.61%-19.66M
44.03%-3.02M
29.81%-4.84M
39.79%-5.68M
-5.42%-6.11M
Operating gains losses
110.09%341K
--773K
----
----
----
---3.38M
--0
--0
----
----
Depreciation and amortization
-3.96%21.82M
0.53%5.46M
0.05%5.51M
-6.37%5.48M
-9.44%5.36M
-28.87%22.72M
-22.89%5.43M
-32.89%5.51M
-30.00%5.86M
-28.85%5.92M
Asset impairment expenditure
----
----
----
----
----
--0
--0
--0
----
----
Unrealized gains and losses of investment securities
--0
--0
--0
--0
--0
-81.79%526K
101.14%3K
-99.11%18K
-44.21%318K
-66.06%187K
Remuneration paid in stock
18.24%1.91M
-97.40%11K
53.62%785K
8.90%465K
154.30%651K
400.56%1.62M
170.38%423K
2,789.47%511K
211.68%427K
565.45%256K
Deferred tax
-134.10%-1.3M
-1,388.14%-760K
-31.91%-62K
-104.90%-189K
-373.77%-289K
647.70%3.81M
-44.86%59K
91.31%-47K
4,642.35%3.86M
65.54%-61K
Other non cashItems
67.70%2.06M
-63.38%115K
277.05%1.33M
9.03%302K
9.22%308K
53.83%1.23M
44.70%314K
77.39%353K
45.79%277K
47.64%282K
Change In working capital
314.90%4.73M
44,900.00%2.24M
-37,050.00%-739K
52.31%1.28M
547.51%1.95M
-77.35%1.14M
-100.46%-5K
-99.92%2K
46.61%843K
-69.38%301K
-Change in receivables
-99.96%1K
-81.38%452K
156.89%706K
-364.16%-914K
-129.03%-243K
221.14%2.37M
998.64%2.43M
-207.54%-1.24M
120.34%346K
-21.33%837K
-Change in inventory
776.19%1.28M
49.18%-928K
-133.25%-405K
-15.64%1M
308.83%1.61M
71.41%-189K
-197.88%-1.83M
19.41%1.22M
70.83%1.19M
56.35%-770K
-Change in payables and accrued expense
124.87%1.1M
92.37%-279K
192.76%2.47M
-3.67%-1.16M
114.55%72K
-294.94%-4.43M
-764.78%-3.66M
-46.13%842K
-286.16%-1.12M
-134.86%-495K
-Change in other current assets
-40.32%265K
-20.72%264K
-0.68%584K
-20.13%-901K
16.48%318K
123.12%444K
-3.48%333K
279.35%588K
-126.59%-750K
810.00%273K
-Change in other working capital
-29.02%2.09M
0.48%2.73M
-191.03%-4.09M
177.09%3.25M
-57.46%194K
18.19%2.94M
74.57%2.72M
6.33%-1.41M
-46.64%1.17M
95.71%456K
Cash from discontinued investing activities
Operating cash flow
114.04%17.13M
103.03%6.51M
64.96%2.48M
82.77%4.6M
355.40%3.54M
-49.31%8M
-14.17%3.21M
-72.03%1.5M
-5.58%2.52M
-80.65%778K
Investing cash flow
Cash flow from continuing investing activities
-114.51%-1.7M
-2,330.77%-316K
81.40%-279K
-108.20%-1.09M
-950.00%-21K
6,308.99%11.74M
7.14%-13K
-3,650.00%-1.5M
9,914.81%13.25M
-2K
Net PPE purchase and sale
-1,266.67%-205K
-153.85%-33K
---64K
---87K
-950.00%-21K
63.41%-15K
7.14%-13K
--0
--0
---2K
Net intangibles purchas and sale
-111.31%-1.5M
---283K
---215K
----
----
9,052.70%13.25M
--0
--0
----
----
Net business purchase and sale
--0
--0
----
----
----
---1.5M
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
-114.51%-1.7M
-2,330.77%-316K
81.40%-279K
-108.20%-1.09M
-950.00%-21K
6,308.99%11.74M
7.14%-13K
-3,650.00%-1.5M
9,914.81%13.25M
---2K
Financing cash flow
Cash flow from continuing financing activities
7.74%-21.56M
-102.26%-5.37M
77.19%-3.44M
-266.86%-9.47M
-8.08%-3.28M
-59.60%-23.36M
31.70%-2.65M
-251.81%-15.1M
12.48%-2.58M
13.66%-3.03M
Net issuance payments of debt
14.85%-18.37M
-95.67%-5.19M
90.45%-1.44M
-437.82%-8.63M
-39.90%-3.1M
-127.97%-21.57M
19.72%-2.65M
-548.45%-15.1M
-3.75%-1.61M
2.80%-2.22M
Net common stock issuance
-199.83%-1.8M
---7K
---783K
-162.78%-833K
37.81%-176K
61.34%-600K
--0
--0
-71.35%-317K
-53.80%-283K
Cash dividends paid
----
----
----
----
----
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
----
----
----
----
----
--0
--0
--0
--0
--0
Net other financing activities
-16.54%-1.39M
---168K
----
----
----
12.43%-1.19M
--0
--0
---658K
---533K
Cash from discontinued financing activities
Financing cash flow
7.74%-21.56M
-102.26%-5.37M
77.19%-3.44M
-266.86%-9.47M
-8.08%-3.28M
-59.60%-23.36M
31.70%-2.65M
-251.81%-15.1M
12.48%-2.58M
13.66%-3.03M
Net cash flow
Beginning cash position
-20.48%17.46M
-38.55%10.78M
-62.62%12.15M
-8.79%17.73M
-20.48%17.46M
5.93%21.95M
-19.57%17.54M
55.34%32.52M
-8.35%19.44M
5.93%21.95M
Current changes in cash
-69.03%-6.13M
52.97%823K
91.74%-1.25M
-145.10%-5.95M
110.76%243K
-477.32%-3.63M
424.10%538K
-1,557.05%-15.1M
3,278.07%13.19M
-546.25%-2.26M
Effect of exchange rate changes
145.52%396K
119.61%122K
-206.67%-128K
413.68%367K
113.94%35K
-424.63%-870K
-300.65%-622K
175.00%120K
-187.97%-117K
-1,573.33%-251K
End cash Position
-32.84%11.72M
-32.84%11.72M
-38.55%10.78M
-62.62%12.15M
-8.79%17.73M
-20.48%17.46M
-20.48%17.46M
-19.57%17.54M
55.34%32.52M
-8.35%19.44M
Free cash from
93.13%15.43M
93.95%6.19M
46.37%2.2M
39.62%3.52M
353.87%3.52M
-48.79%7.99M
-14.19%3.19M
-71.82%1.5M
-0.55%2.52M
-80.70%776K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 114.04%17.13M103.03%6.51M64.96%2.48M82.77%4.6M355.40%3.54M-49.31%8M-14.17%3.21M-72.03%1.5M-5.58%2.52M-80.65%778K
Net income from continuing operations 36.76%-12.43M55.84%-1.34M19.12%-3.92M51.76%-2.74M27.35%-4.44M28.61%-19.66M44.03%-3.02M29.81%-4.84M39.79%-5.68M-5.42%-6.11M
Operating gains losses 110.09%341K--773K---------------3.38M--0--0--------
Depreciation and amortization -3.96%21.82M0.53%5.46M0.05%5.51M-6.37%5.48M-9.44%5.36M-28.87%22.72M-22.89%5.43M-32.89%5.51M-30.00%5.86M-28.85%5.92M
Asset impairment expenditure ----------------------0--0--0--------
Unrealized gains and losses of investment securities --0--0--0--0--0-81.79%526K101.14%3K-99.11%18K-44.21%318K-66.06%187K
Remuneration paid in stock 18.24%1.91M-97.40%11K53.62%785K8.90%465K154.30%651K400.56%1.62M170.38%423K2,789.47%511K211.68%427K565.45%256K
Deferred tax -134.10%-1.3M-1,388.14%-760K-31.91%-62K-104.90%-189K-373.77%-289K647.70%3.81M-44.86%59K91.31%-47K4,642.35%3.86M65.54%-61K
Other non cashItems 67.70%2.06M-63.38%115K277.05%1.33M9.03%302K9.22%308K53.83%1.23M44.70%314K77.39%353K45.79%277K47.64%282K
Change In working capital 314.90%4.73M44,900.00%2.24M-37,050.00%-739K52.31%1.28M547.51%1.95M-77.35%1.14M-100.46%-5K-99.92%2K46.61%843K-69.38%301K
-Change in receivables -99.96%1K-81.38%452K156.89%706K-364.16%-914K-129.03%-243K221.14%2.37M998.64%2.43M-207.54%-1.24M120.34%346K-21.33%837K
-Change in inventory 776.19%1.28M49.18%-928K-133.25%-405K-15.64%1M308.83%1.61M71.41%-189K-197.88%-1.83M19.41%1.22M70.83%1.19M56.35%-770K
-Change in payables and accrued expense 124.87%1.1M92.37%-279K192.76%2.47M-3.67%-1.16M114.55%72K-294.94%-4.43M-764.78%-3.66M-46.13%842K-286.16%-1.12M-134.86%-495K
-Change in other current assets -40.32%265K-20.72%264K-0.68%584K-20.13%-901K16.48%318K123.12%444K-3.48%333K279.35%588K-126.59%-750K810.00%273K
-Change in other working capital -29.02%2.09M0.48%2.73M-191.03%-4.09M177.09%3.25M-57.46%194K18.19%2.94M74.57%2.72M6.33%-1.41M-46.64%1.17M95.71%456K
Cash from discontinued investing activities
Operating cash flow 114.04%17.13M103.03%6.51M64.96%2.48M82.77%4.6M355.40%3.54M-49.31%8M-14.17%3.21M-72.03%1.5M-5.58%2.52M-80.65%778K
Investing cash flow
Cash flow from continuing investing activities -114.51%-1.7M-2,330.77%-316K81.40%-279K-108.20%-1.09M-950.00%-21K6,308.99%11.74M7.14%-13K-3,650.00%-1.5M9,914.81%13.25M-2K
Net PPE purchase and sale -1,266.67%-205K-153.85%-33K---64K---87K-950.00%-21K63.41%-15K7.14%-13K--0--0---2K
Net intangibles purchas and sale -111.31%-1.5M---283K---215K--------9,052.70%13.25M--0--0--------
Net business purchase and sale --0--0---------------1.5M--0------------
Cash from discontinued investing activities
Investing cash flow -114.51%-1.7M-2,330.77%-316K81.40%-279K-108.20%-1.09M-950.00%-21K6,308.99%11.74M7.14%-13K-3,650.00%-1.5M9,914.81%13.25M---2K
Financing cash flow
Cash flow from continuing financing activities 7.74%-21.56M-102.26%-5.37M77.19%-3.44M-266.86%-9.47M-8.08%-3.28M-59.60%-23.36M31.70%-2.65M-251.81%-15.1M12.48%-2.58M13.66%-3.03M
Net issuance payments of debt 14.85%-18.37M-95.67%-5.19M90.45%-1.44M-437.82%-8.63M-39.90%-3.1M-127.97%-21.57M19.72%-2.65M-548.45%-15.1M-3.75%-1.61M2.80%-2.22M
Net common stock issuance -199.83%-1.8M---7K---783K-162.78%-833K37.81%-176K61.34%-600K--0--0-71.35%-317K-53.80%-283K
Cash dividends paid ----------------------0--0--0--0--0
Proceeds from stock option exercised by employees ----------------------0--0--0--0--0
Net other financing activities -16.54%-1.39M---168K------------12.43%-1.19M--0--0---658K---533K
Cash from discontinued financing activities
Financing cash flow 7.74%-21.56M-102.26%-5.37M77.19%-3.44M-266.86%-9.47M-8.08%-3.28M-59.60%-23.36M31.70%-2.65M-251.81%-15.1M12.48%-2.58M13.66%-3.03M
Net cash flow
Beginning cash position -20.48%17.46M-38.55%10.78M-62.62%12.15M-8.79%17.73M-20.48%17.46M5.93%21.95M-19.57%17.54M55.34%32.52M-8.35%19.44M5.93%21.95M
Current changes in cash -69.03%-6.13M52.97%823K91.74%-1.25M-145.10%-5.95M110.76%243K-477.32%-3.63M424.10%538K-1,557.05%-15.1M3,278.07%13.19M-546.25%-2.26M
Effect of exchange rate changes 145.52%396K119.61%122K-206.67%-128K413.68%367K113.94%35K-424.63%-870K-300.65%-622K175.00%120K-187.97%-117K-1,573.33%-251K
End cash Position -32.84%11.72M-32.84%11.72M-38.55%10.78M-62.62%12.15M-8.79%17.73M-20.48%17.46M-20.48%17.46M-19.57%17.54M55.34%32.52M-8.35%19.44M
Free cash from 93.13%15.43M93.95%6.19M46.37%2.2M39.62%3.52M353.87%3.52M-48.79%7.99M-14.19%3.19M-71.82%1.5M-0.55%2.52M-80.70%776K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +5.69%
Sample Name
Sample Code
 +0.44%
Sample Name
Sample Code
 -2.38%
4
CHINA OILFIELD
02883
-3.34%
5
CNOOC
00883
-5.23%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +30.01%
Sample Name
Sample Code
 +22.47%
Sample Name
Sample Code
 +20.53%
4
Rockchip Electronics
603893
+19.38%
5
Ucloud Technology Co., Ltd
688158
+18.90%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -